Intimation under Regulation 30 of SEBI (LODR) Regulation 2015

At the 38th Annual General Meeting held on September 30, 2025, shareholders of Fredun Pharmaceuticals approved three key appointments. Ms. Sonal Dharmin Desai and Mr. Anshu Agarwal were confirmed as Non-Executive Independent Directors for a 5-year term each, having previously been appointed as Additional Directors on July 30, 2025. Both are unrelated to existing board members. Ms. Kala Agarwal, a Practicing Company Secretary with over 20 years of experience, was also approved as Secretarial Auditor for 5 consecutive financial years from FY 2025-26 to FY 2029-30. The company confirmed none of the appointees are debarred from holding office under any SEBI order.